ACTEMRA
HOFFMANN-LA ROCHE LIMITED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of ACTEMRA in Canada?
Not currently. The most recent shortage report for ACTEMRA 162MG is marked resolved (last updated November 25, 2021).
Avtozma, Actemra & Tyenne (Tocilizumab) Shortage in Canada
Whether tocilizumab — Actemra and its biosimilars Avtozma and Tyenne — is in shortage in Canada right now, what anticipated and avoided shortage reports mean, and what to ask before switching brands.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02483327
Strength
162MG
Dosage Form
SOLUTION
Route
SUBCUTANEOUS
Active Ingredient
TOCILIZUMAB
Tier
Unrated
Last Updated
2021-11-25
Reason for Shortage
Other (Please describe in comments)
Other Products from HOFFMANN-LA ROCHE LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
400MG · DIN 02350114
200MG · DIN 02350106
162MG · DIN 02424770
80MG · DIN 02350092
DIN 02225689
DIN 02147440
150MG · DIN 02458136
25MG · DIN 02270994
2MG · DIN 02245859
200MG · DIN 02242145
250MG · DIN 02192748
500MG · DIN 02237484